In the present study, we showed that the R1157W mutation is an activating oncogenic mutation for CRC progression because the SMARCA4-R1157W mutation significantly increased ATPase activity and chromatin remodeling activities. This evidence concerns the gene DNAH8 and colorectal carcinoma.